AQbD-Based Development and Green Analytical Assessment of a Stability-Indicating HPTLC Method for Bilastine, Dextromethorphan HBr, and Phenylephrine HCl in Pharmaceutical Formulations
This study presents the development and validation of a robust, stability-indicating, and eco-friendly HPTLC method for the simultaneous quantification of Bilastine, Dextromethorphan HBr, and Phenylephrine HCl in pharmaceutical formulations, utilizing an AQbD approach and achieving a greenness score of 0.62 via AGREE software.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Every day, millions of people reach for medicine to quiet a sneezing fit, clear a stuffy nose, or stop a dry cough. These symptoms often arrive together, and modern pharmacies offer combination pills that contain three distinct drugs working in harmony: one to block the body's allergic reaction, another to calm the cough reflex, and a third to shrink swollen nasal passages. For these medicines to be safe and effective, manufacturers must ensure that every tablet contains the exact right amount of each ingredient and that the drugs remain stable over time. This requires precise testing methods that can spot even tiny changes in the chemical makeup of the medicine, distinguishing the active ingredients from any breakdown products that might form if the drug is exposed to heat, light, or moisture.
In a recent study, researchers set out to create a better way to perform this essential testing for a specific combination of three drugs: Bilastine, Dextromethorphan HBr, and Phenylephrine HCl. They developed a new technique using a method called high-performance thin-layer chromatography, which is essentially a sophisticated form of paper chromatography. Imagine a flat, glass-like plate coated with a fine layer of silica gel, similar to the sand found on a beach but processed to be incredibly smooth and uniform. When a tiny drop of the medicine is placed on this plate and the bottom edge is dipped into a solvent, the liquid travels up the plate, carrying the different chemical components with it at different speeds. Because each drug interacts with the solvent and the plate in its own unique way, they separate into distinct spots, allowing scientists to identify and measure them individually.
The team, working at Parul University in India, did not simply guess how to set up this test. Instead, they used a systematic planning approach known as Analytical Quality by Design. This method treats the development of a test like engineering a bridge, where every variable is mapped out in advance to ensure the final structure is strong and reliable. They identified three key factors that could change how the drugs moved across the plate: the volume of a specific solvent called chloroform, the amount of time the chamber was allowed to saturate with solvent vapor, and the wavelength of light used to detect the drugs. By testing many different combinations of these factors, they found the perfect settings that allowed all three drugs to separate cleanly and clearly. The optimal conditions involved a specific mixture of four solvents and a precise scanning wavelength of 283 nanometers, a shade of light invisible to the human eye but perfect for seeing these specific chemicals.
Once the method was established, the researchers put it through a rigorous series of checks to prove it could handle real-world challenges. They tested the method's ability to measure the drugs accurately across a wide range of concentrations, confirming that the results were consistent whether the amount of drug was small or large. They also subjected the drugs to harsh conditions, including exposure to strong acids, bases, hydrogen peroxide, heat, and ultraviolet light. In every case, the new method successfully separated the original drugs from their degraded forms, proving that it is a "stability-indicating" tool capable of detecting when a medicine has started to break down. The tests showed that the method is highly precise, with very little variation in results when repeated, and it is sensitive enough to detect minute traces of the drugs, down to less than two nanograms per band.
Beyond the technical success, the researchers also evaluated how environmentally friendly their new method was. Traditional testing often uses large amounts of toxic chemicals, but this new approach was designed to use far less solvent and generate less waste. Using a specialized scoring system that measures the ecological footprint of an analytical procedure, the method received a score of 0.62 out of a possible 1.0. This score indicates that the technique aligns well with modern green chemistry standards, offering a cleaner, more sustainable alternative for routine quality control in pharmaceutical manufacturing. The study concludes that this new, carefully designed method provides a fast, reliable, and eco-conscious way to ensure that combination cold and allergy medicines are safe for patients to use.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.